Quick Answer: Retatrutide is an investigational weight loss drug from Eli Lilly that targets three hormone receptors (GLP-1, GIP, and glucagon) one more than Mounjaro and two more than Ozempic
Plasma semaglutide concentrations were measured following IcoSema and semaglutide administration using a validated liquid chromatographytandem mass spectrometry assay
This research shows that even very similar drugs can have slight differences in their actions, which could be important for how they affect the body
$0 until approved Price stays the same no matter the dose Clinically studied results About 14% average body weight loss* A once-weekly GLP-1 treatment studied alongside lifestyle support
3,4 This is why GLP-1 RAs were initially studied exclusively for diabetes management
Look and feel younger by keeping your cells healthy and strong Empower your bodys detoxification process, so you operate effectively Encourage cell revitalization and regeneration Improve overall body energy and metabolism Detoxify the liver and cells, so youre protected against diseases Promotes clear cognitive brain function and concentration